HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The sustained expression of Cas9 targeting toxic RNAs reverses disease phenotypes in mouse models of myotonic dystrophy type 1.

Abstract
Myotonic dystrophy type I (DM1) is a multisystemic autosomal-dominant inherited human disorder that is caused by CTG microsatellite repeat expansions (MREs) in the 3' untranslated region of DMPK. Toxic RNAs expressed from such repetitive sequences can be eliminated using CRISPR-mediated RNA targeting, yet evidence of its in vivo efficacy and durability is lacking. Here, using adult and neonatal mouse models of DM1, we show that intramuscular or systemic injections of adeno-associated virus (AAV) vectors encoding nuclease-dead Cas9 and a single-guide RNA targeting CUG repeats results in the expression of the RNA-targeting Cas9 for up to three months, redistribution of the RNA-splicing protein muscleblind-like splicing regulator 1, elimination of foci of toxic RNA, reversal of splicing biomarkers and amelioration of myotonia. The sustained reversal of DM1 phenotypes provides further support that RNA-targeting Cas9 is a viable strategy for treating DM1 and other MRE-associated diseases.
AuthorsRanjan Batra, David A Nelles, Daniela M Roth, Florian Krach, Curtis A Nutter, Takahiro Tadokoro, James D Thomas, Łukasz J Sznajder, Steven M Blue, Haydee L Gutierrez, Patrick Liu, Stefan Aigner, Oleksandr Platoshyn, Atsushi Miyanohara, Martin Marsala, Maurice S Swanson, Gene W Yeo
JournalNature biomedical engineering (Nat Biomed Eng) Vol. 5 Issue 2 Pg. 157-168 (02 2021) ISSN: 2157-846X [Electronic] England
PMID32929188 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA
  • CRISPR-Associated Protein 9
Topics
  • Adenoviridae (physiology)
  • Animals
  • CRISPR-Associated Protein 9 (metabolism)
  • CRISPR-Cas Systems
  • Disease Models, Animal
  • Female
  • Gene Editing (methods)
  • Genetic Vectors (physiology)
  • Male
  • Mice, Transgenic
  • Muscle, Skeletal (metabolism)
  • Myotonic Dystrophy (genetics, metabolism)
  • Phenotype
  • RNA (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: